Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Reposition Discontinued Drug Candidates for Merck Serono

NEW YORK (GenomeWeb News) — Gene Logic today said it will help Merck Serono, a division of German drug maker Merck, identify alternative development paths for “several” undisclosed drug candidates.
 
All of the candidates were discontinued or “de-prioritized” in clinical trials for reasons other than safety, according to Gene Logic.
 
Under the deal, Gene Logic stands to pocket milestones and royalties “similar to those paid for development-stage in-licensing deals,” though discounted for an undisclosed amount because Merck Serono originally discovered the compounds.
 
The deal also gives Gene Logic the option to receive an exclusive license to any candidate for which the company identifies a “new potential therapeutic use” that Merck Serono chooses not to develop. In that case, Merck Serono would stand to receive milestones and royalties, Gene Logic said.
 
Though the companies did not disclose the indications for which these candidates would be considered, Gene Logic in a statement called Merck Serono a “world leader” in reproductive health with “strong market positions in several other therapeutic areas.”

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.